Literature DB >> 12393566

Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation.

Frans L A Willekens1, Bregt Roerdinkholder-Stoelwinder, Yvonne A M Groenen-Döpp, Harry J Bos, Giel J C G M Bosman, Annegeet G van den Bos, Arie J Verkleij, Jan M Werre.   

Abstract

Previous studies have shown that approximately 20% of hemoglobin is lost from circulating red blood cells (RBCs), mainly during the second half of the cells' life span. Because hemoglobin-containing vesicles are known to circulate in plasma, these vesicles were isolated. Flow cytometry studies showed that most RBC-derived vesicles contain hemoglobin with all hemoglobin components present. The hemoglobin composition of the vesicles resembled that of old RBCs. RBC cohort studies using isotope-labeled glycine have been described, which showed a continuous presence of this label in hemoglobin degradation products. The label concentration of these products increased during the second half of the RBC life span, accompanied by a decrease within the RBC. It is concluded that the hemoglobin loss from circulating RBCs of all ages can be explained by shedding hemoglobin-containing vesicles. This loss occurs predominantly in older RBCs. Apparently the spleen facilitates this process since asplenia vesicle retention within RBCs of all ages has been described, accompanied by an increase in the percentage of total HbA(1). The present study shows that in old RBCs of asplenic individuals, the decrease of hemoglobin content per cell such as seen in old RBCs of control individuals is absent due to an increase in the absolute amount of HbA(1c) and HbA(1e2). It is concluded that hemoglobin-containing vesicles within old RBCs are "pitted" by the spleen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393566     DOI: 10.1182/blood-2002-02-0500

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Modeling red blood cell survival data.

Authors:  Julia Korell; Frederiek E Vos; Carolyn V Coulter; John B Schollum; Robert J Walker; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-14       Impact factor: 2.745

Review 2.  Aging and death signalling in mature red cells: from basic science to transfusion practice.

Authors:  Marianna H Antonelou; Anastasios G Kriebardis; Issidora S Papassideri
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

3.  Measurement of red cell lifespan and aging.

Authors:  Robert S Franco
Journal:  Transfus Med Hemother       Date:  2012-08-27       Impact factor: 3.747

4.  Circulating red cell-derived microparticles in human malaria.

Authors:  Duangdao Nantakomol; Arjen M Dondorp; Srivicha Krudsood; Rachanee Udomsangpetch; Kovit Pattanapanyasat; Valery Combes; Georges E Grau; Nicholas J White; Parnpen Viriyavejakul; Nicholas P J Day; Kesinee Chotivanich
Journal:  J Infect Dis       Date:  2011-03-01       Impact factor: 5.226

Review 5.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 6.  Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?

Authors:  Anastasios Kriebardis; Marianna Antonelou; Konstantinos Stamoulis; Issidora Papassideri
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 7.  Red blood cell deformability during storage: towards functional proteomics and metabolomics in the Blood Bank.

Authors:  Judith C A Cluitmans; Max R Hardeman; Sip Dinkla; Roland Brock; Giel J C G M Bosman
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 8.  Metabolomics Signatures of Aging: Recent Advances.

Authors:  Sunil S Adav; Yulan Wang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

Review 9.  Influence of red blood cell-derived microparticles upon vasoregulation.

Authors:  Ahmed S Said; Allan Doctor
Journal:  Blood Transfus       Date:  2017-05-15       Impact factor: 3.443

10.  Age-structured population model of cell survival.

Authors:  Wojciech Krzyzanski; Pawel Wiczling; Asfiha Gebre
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-03-29       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.